Other Key Personnel
Overview This project proposes to increase the number of providers that are waivered providers for buprenorphine and also seeks to increase support for providers engaged in MAT utilizing traditional telemedicine support as well as a Project ECHO approach to enhance the independence of MAT clinicians.
Site Principal Investigator: Michael Mancino, MD/Project Principal Investigator: Michael Wilson, MD
The aims of this project are to 1) expand distribution of Narcan rescue medication to those at high risk for opioid overdose as well as those who know of those at risk for opioid overdose and 2) facilitate transition of ED patients presenting to the ED with opioid use disorder to medication assisted treatment by inducting patients on buprenorphine and transferring them to a local substance abuse treatment clinic for longer-term care.
|